English
简体中文
Total: £ 56.28
Published Date: 2026-03-30 | Pages: 107 | Tables: 106 | Medical Care
The global Natural Killer Cell Therapeutics market was valued at US$ 254 million in 2025 and is anticipated to reach US$ 2489 million by 2032, at a CAGR of 39.1% from 2026 to 2032.
NK cells, a type of immune cell, have received a lot of attention for their natural capacity to recognize and kill malignant cells. Advances in understanding NK cell biology and its interactions with Cancer have resulted in the development of new medicines that harness the potential of these cells. With the success of CAR-NK cell therapies in preclinical and early clinical trials, there is growing optimism about the ability of NK cell-based immunotherapies to treat a wide spectrum of cancer types.
Another important driver for the NK Cell Therapeutics Market is the rising global prevalence of Cancer, combined with ongoing unmet medical needs in cancer treatment. Despite advances in traditional medicines such as chemotherapy and targeted therapy, certain malignancies continue to be refractory or develop treatment resistance. This highlights the critical need for novel therapeutic approaches, such as NK cell-based immunotherapy, which has the potential to improve efficacy while reducing adverse effects. As the cancer burden grows, fuelled by factors such as aging populations and lifestyle changes, there is an increasing need to discover effective medicines, driving demand for NK cell therapeutics.
This report delivers a comprehensive overview of the global Natural Killer Cell Therapeutics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Natural Killer Cell Therapeutics. The Natural Killer Cell Therapeutics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Natural Killer Cell Therapeutics market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Natural Killer Cell Therapeutics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Merck KGaA
Bristol-Myers Squibb Company
Glycostem
Sanofi
Cytovia Therapeutics
ImmunityBio, Inc.
Biohaven Pharmaceuticals
Fate Therapeutics
EMERcell
Phio Pharmaceuticals
Segment by Type
NK Cell Therapies
NK Cell Directed Antibodies
Segment by Application
Research & Academic Institutes
Hospitals
Specialty Clinics
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Natural Killer Cell Therapeutics companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Natural Killer Cell Therapeutics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 NK Cell Therapies
1.2.3 NK Cell Directed Antibodies
1.3 Market by Application
1.3.1 Global Natural Killer Cell Therapeutics Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Research & Academic Institutes
1.3.3 Hospitals
1.3.4 Specialty Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Natural Killer Cell Therapeutics Market Perspective (2021–2032)
2.2 Global Natural Killer Cell Therapeutics Growth Trends by Region
2.2.1 Global Natural Killer Cell Therapeutics Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Natural Killer Cell Therapeutics Historic Market Size by Region (2021–2026)
2.2.3 Natural Killer Cell Therapeutics Forecasted Market Size by Region (2027–2032)
2.3 Natural Killer Cell Therapeutics Market Dynamics
2.3.1 Natural Killer Cell Therapeutics Industry Trends
2.3.2 Natural Killer Cell Therapeutics Market Drivers
2.3.3 Natural Killer Cell Therapeutics Market Challenges
2.3.4 Natural Killer Cell Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Natural Killer Cell Therapeutics Players by Revenue
3.1.1 Global Top Natural Killer Cell Therapeutics Players by Revenue (2021–2026)
3.1.2 Global Natural Killer Cell Therapeutics Revenue Market Share by Players (2021–2026)
3.2 Global Top Natural Killer Cell Therapeutics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Natural Killer Cell Therapeutics Revenue
3.4 Global Natural Killer Cell Therapeutics Market Concentration Ratio
3.4.1 Global Natural Killer Cell Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Natural Killer Cell Therapeutics Revenue in 2025
3.5 Global Key Players of Natural Killer Cell Therapeutics Head Offices and Areas Served
3.6 Global Key Players of Natural Killer Cell Therapeutics, Products and Applications
3.7 Global Key Players of Natural Killer Cell Therapeutics, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Natural Killer Cell Therapeutics Breakdown Data by Type
4.1 Global Natural Killer Cell Therapeutics Historic Market Size by Type (2021–2026)
4.2 Global Natural Killer Cell Therapeutics Forecasted Market Size by Type (2027–2032)
5 Natural Killer Cell Therapeutics Breakdown Data by Application
5.1 Global Natural Killer Cell Therapeutics Historic Market Size by Application (2021–2026)
5.2 Global Natural Killer Cell Therapeutics Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Natural Killer Cell Therapeutics Market Size (2021–2032)
6.2 North America Natural Killer Cell Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Natural Killer Cell Therapeutics Market Size by Country (2021–2026)
6.4 North America Natural Killer Cell Therapeutics Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Natural Killer Cell Therapeutics Market Size (2021–2032)
7.2 Europe Natural Killer Cell Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Natural Killer Cell Therapeutics Market Size by Country (2021–2026)
7.4 Europe Natural Killer Cell Therapeutics Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Natural Killer Cell Therapeutics Market Size (2021–2032)
8.2 Asia-Pacific Natural Killer Cell Therapeutics Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Natural Killer Cell Therapeutics Market Size by Region (2021–2026)
8.4 Asia-Pacific Natural Killer Cell Therapeutics Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Natural Killer Cell Therapeutics Market Size (2021–2032)
9.2 Latin America Natural Killer Cell Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Natural Killer Cell Therapeutics Market Size by Country (2021–2026)
9.4 Latin America Natural Killer Cell Therapeutics Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Natural Killer Cell Therapeutics Market Size (2021–2032)
10.2 Middle East & Africa Natural Killer Cell Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Natural Killer Cell Therapeutics Market Size by Country (2021–2026)
10.4 Middle East & Africa Natural Killer Cell Therapeutics Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Natural Killer Cell Therapeutics Introduction
11.1.4 Merck KGaA Revenue in Natural Killer Cell Therapeutics Business (2021–2026)
11.1.5 Merck KGaA Recent Development
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Company Details
11.2.2 Bristol-Myers Squibb Company Business Overview
11.2.3 Bristol-Myers Squibb Company Natural Killer Cell Therapeutics Introduction
11.2.4 Bristol-Myers Squibb Company Revenue in Natural Killer Cell Therapeutics Business (2021–2026)
11.2.5 Bristol-Myers Squibb Company Recent Development
11.3 Glycostem
11.3.1 Glycostem Company Details
11.3.2 Glycostem Business Overview
11.3.3 Glycostem Natural Killer Cell Therapeutics Introduction
11.3.4 Glycostem Revenue in Natural Killer Cell Therapeutics Business (2021–2026)
11.3.5 Glycostem Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Natural Killer Cell Therapeutics Introduction
11.4.4 Sanofi Revenue in Natural Killer Cell Therapeutics Business (2021–2026)
11.4.5 Sanofi Recent Development
11.5 Cytovia Therapeutics
11.5.1 Cytovia Therapeutics Company Details
11.5.2 Cytovia Therapeutics Business Overview
11.5.3 Cytovia Therapeutics Natural Killer Cell Therapeutics Introduction
11.5.4 Cytovia Therapeutics Revenue in Natural Killer Cell Therapeutics Business (2021–2026)
11.5.5 Cytovia Therapeutics Recent Development
11.6 ImmunityBio, Inc.
11.6.1 ImmunityBio, Inc. Company Details
11.6.2 ImmunityBio, Inc. Business Overview
11.6.3 ImmunityBio, Inc. Natural Killer Cell Therapeutics Introduction
11.6.4 ImmunityBio, Inc. Revenue in Natural Killer Cell Therapeutics Business (2021–2026)
11.6.5 ImmunityBio, Inc. Recent Development
11.7 Biohaven Pharmaceuticals
11.7.1 Biohaven Pharmaceuticals Company Details
11.7.2 Biohaven Pharmaceuticals Business Overview
11.7.3 Biohaven Pharmaceuticals Natural Killer Cell Therapeutics Introduction
11.7.4 Biohaven Pharmaceuticals Revenue in Natural Killer Cell Therapeutics Business (2021–2026)
11.7.5 Biohaven Pharmaceuticals Recent Development
11.8 Fate Therapeutics
11.8.1 Fate Therapeutics Company Details
11.8.2 Fate Therapeutics Business Overview
11.8.3 Fate Therapeutics Natural Killer Cell Therapeutics Introduction
11.8.4 Fate Therapeutics Revenue in Natural Killer Cell Therapeutics Business (2021–2026)
11.8.5 Fate Therapeutics Recent Development
11.9 EMERcell
11.9.1 EMERcell Company Details
11.9.2 EMERcell Business Overview
11.9.3 EMERcell Natural Killer Cell Therapeutics Introduction
11.9.4 EMERcell Revenue in Natural Killer Cell Therapeutics Business (2021–2026)
11.9.5 EMERcell Recent Development
11.10 Phio Pharmaceuticals
11.10.1 Phio Pharmaceuticals Company Details
11.10.2 Phio Pharmaceuticals Business Overview
11.10.3 Phio Pharmaceuticals Natural Killer Cell Therapeutics Introduction
11.10.4 Phio Pharmaceuticals Revenue in Natural Killer Cell Therapeutics Business (2021–2026)
11.10.5 Phio Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Natural Killer Cell Therapeutics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of NK Cell Therapies
Table 3. Key Players of NK Cell Directed Antibodies
Table 4. Global Natural Killer Cell Therapeutics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Natural Killer Cell Therapeutics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Natural Killer Cell Therapeutics Market Size by Region (US$ Million), 2021–2026
Table 7. Global Natural Killer Cell Therapeutics Market Share by Region (2021–2026)
Table 8. Global Natural Killer Cell Therapeutics Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Natural Killer Cell Therapeutics Market Share by Region (2027–2032)
Table 10. Natural Killer Cell Therapeutics Market Trends
Table 11. Natural Killer Cell Therapeutics Market Drivers
Table 12. Natural Killer Cell Therapeutics Market Challenges
Table 13. Natural Killer Cell Therapeutics Market Restraints
Table 14. Global Natural Killer Cell Therapeutics Revenue by Players (US$ Million), 2021–2026
Table 15. Global Natural Killer Cell Therapeutics Market Share by Players (2021–2026)
Table 16. Global Top Natural Killer Cell Therapeutics Players by Tier (Tier 1, Tier 2, and Tier 3), based on Natural Killer Cell Therapeutics Revenue, 2025
Table 17. Ranking of Global Top Natural Killer Cell Therapeutics Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Natural Killer Cell Therapeutics Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Natural Killer Cell Therapeutics, Headquarters and Area Served
Table 20. Global Key Players of Natural Killer Cell Therapeutics, Products and Applications
Table 21. Global Key Players of Natural Killer Cell Therapeutics, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Natural Killer Cell Therapeutics Market Size by Type (US$ Million), 2021–2026
Table 24. Global Natural Killer Cell Therapeutics Revenue Market Share by Type (2021–2026)
Table 25. Global Natural Killer Cell Therapeutics Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Natural Killer Cell Therapeutics Revenue Market Share by Type (2027–2032)
Table 27. Global Natural Killer Cell Therapeutics Market Size by Application (US$ Million), 2021–2026
Table 28. Global Natural Killer Cell Therapeutics Revenue Market Share by Application (2021–2026)
Table 29. Global Natural Killer Cell Therapeutics Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Natural Killer Cell Therapeutics Revenue Market Share by Application (2027–2032)
Table 31. North America Natural Killer Cell Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Natural Killer Cell Therapeutics Market Size by Country (US$ Million), 2021–2026
Table 33. North America Natural Killer Cell Therapeutics Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Natural Killer Cell Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Natural Killer Cell Therapeutics Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Natural Killer Cell Therapeutics Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Natural Killer Cell Therapeutics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Natural Killer Cell Therapeutics Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Natural Killer Cell Therapeutics Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Natural Killer Cell Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Natural Killer Cell Therapeutics Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Natural Killer Cell Therapeutics Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Natural Killer Cell Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Natural Killer Cell Therapeutics Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Natural Killer Cell Therapeutics Market Size by Country (US$ Million), 2027–2032
Table 46. Merck KGaA Company Details
Table 47. Merck KGaA Business Overview
Table 48. Merck KGaA Natural Killer Cell Therapeutics Product
Table 49. Merck KGaA Revenue in Natural Killer Cell Therapeutics Business (US$ Million), 2021–2026
Table 50. Merck KGaA Recent Development
Table 51. Bristol-Myers Squibb Company Company Details
Table 52. Bristol-Myers Squibb Company Business Overview
Table 53. Bristol-Myers Squibb Company Natural Killer Cell Therapeutics Product
Table 54. Bristol-Myers Squibb Company Revenue in Natural Killer Cell Therapeutics Business (US$ Million), 2021–2026
Table 55. Bristol-Myers Squibb Company Recent Development
Table 56. Glycostem Company Details
Table 57. Glycostem Business Overview
Table 58. Glycostem Natural Killer Cell Therapeutics Product
Table 59. Glycostem Revenue in Natural Killer Cell Therapeutics Business (US$ Million), 2021–2026
Table 60. Glycostem Recent Development
Table 61. Sanofi Company Details
Table 62. Sanofi Business Overview
Table 63. Sanofi Natural Killer Cell Therapeutics Product
Table 64. Sanofi Revenue in Natural Killer Cell Therapeutics Business (US$ Million), 2021–2026
Table 65. Sanofi Recent Development
Table 66. Cytovia Therapeutics Company Details
Table 67. Cytovia Therapeutics Business Overview
Table 68. Cytovia Therapeutics Natural Killer Cell Therapeutics Product
Table 69. Cytovia Therapeutics Revenue in Natural Killer Cell Therapeutics Business (US$ Million), 2021–2026
Table 70. Cytovia Therapeutics Recent Development
Table 71. ImmunityBio, Inc. Company Details
Table 72. ImmunityBio, Inc. Business Overview
Table 73. ImmunityBio, Inc. Natural Killer Cell Therapeutics Product
Table 74. ImmunityBio, Inc. Revenue in Natural Killer Cell Therapeutics Business (US$ Million), 2021–2026
Table 75. ImmunityBio, Inc. Recent Development
Table 76. Biohaven Pharmaceuticals Company Details
Table 77. Biohaven Pharmaceuticals Business Overview
Table 78. Biohaven Pharmaceuticals Natural Killer Cell Therapeutics Product
Table 79. Biohaven Pharmaceuticals Revenue in Natural Killer Cell Therapeutics Business (US$ Million), 2021–2026
Table 80. Biohaven Pharmaceuticals Recent Development
Table 81. Fate Therapeutics Company Details
Table 82. Fate Therapeutics Business Overview
Table 83. Fate Therapeutics Natural Killer Cell Therapeutics Product
Table 84. Fate Therapeutics Revenue in Natural Killer Cell Therapeutics Business (US$ Million), 2021–2026
Table 85. Fate Therapeutics Recent Development
Table 86. EMERcell Company Details
Table 87. EMERcell Business Overview
Table 88. EMERcell Natural Killer Cell Therapeutics Product
Table 89. EMERcell Revenue in Natural Killer Cell Therapeutics Business (US$ Million), 2021–2026
Table 90. EMERcell Recent Development
Table 91. Phio Pharmaceuticals Company Details
Table 92. Phio Pharmaceuticals Business Overview
Table 93. Phio Pharmaceuticals Natural Killer Cell Therapeutics Product
Table 94. Phio Pharmaceuticals Revenue in Natural Killer Cell Therapeutics Business (US$ Million), 2021–2026
Table 95. Phio Pharmaceuticals Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Natural Killer Cell Therapeutics Picture
Figure 2. Global Natural Killer Cell Therapeutics Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Natural Killer Cell Therapeutics Market Share by Type: 2025 vs 2032
Figure 4. NK Cell Therapies Features
Figure 5. NK Cell Directed Antibodies Features
Figure 6. Global Natural Killer Cell Therapeutics Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Natural Killer Cell Therapeutics Market Share by Application: 2025 vs 2032
Figure 8. Research & Academic Institutes Case Studies
Figure 9. Hospitals Case Studies
Figure 10. Specialty Clinics Case Studies
Figure 11. Natural Killer Cell Therapeutics Report Years Considered
Figure 12. Global Natural Killer Cell Therapeutics Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global Natural Killer Cell Therapeutics Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Natural Killer Cell Therapeutics Market Share by Region: 2025 vs 2032
Figure 15. Global Natural Killer Cell Therapeutics Market Share by Players in 2025
Figure 16. Global Natural Killer Cell Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Natural Killer Cell Therapeutics Revenue in 2025
Figure 18. North America Natural Killer Cell Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America Natural Killer Cell Therapeutics Market Share by Country (2021–2032)
Figure 20. United States Natural Killer Cell Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada Natural Killer Cell Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Natural Killer Cell Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Natural Killer Cell Therapeutics Market Share by Country (2021–2032)
Figure 24. Germany Natural Killer Cell Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France Natural Killer Cell Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. Natural Killer Cell Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy Natural Killer Cell Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia Natural Killer Cell Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland Natural Killer Cell Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Natural Killer Cell Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Natural Killer Cell Therapeutics Market Share by Region (2021–2032)
Figure 32. China Natural Killer Cell Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan Natural Killer Cell Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea Natural Killer Cell Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia Natural Killer Cell Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India Natural Killer Cell Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand Natural Killer Cell Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Natural Killer Cell Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Natural Killer Cell Therapeutics Market Share by Country (2021–2032)
Figure 40. Mexico Natural Killer Cell Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil Natural Killer Cell Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Natural Killer Cell Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Natural Killer Cell Therapeutics Market Share by Country (2021–2032)
Figure 44. Israel Natural Killer Cell Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia Natural Killer Cell Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE Natural Killer Cell Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Merck KGaA Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2021–2026)
Figure 48. Bristol-Myers Squibb Company Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2021–2026)
Figure 49. Glycostem Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2021–2026)
Figure 50. Sanofi Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2021–2026)
Figure 51. Cytovia Therapeutics Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2021–2026)
Figure 52. ImmunityBio, Inc. Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2021–2026)
Figure 53. Biohaven Pharmaceuticals Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2021–2026)
Figure 54. Fate Therapeutics Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2021–2026)
Figure 55. EMERcell Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2021–2026)
Figure 56. Phio Pharmaceuticals Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2021–2026)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
